Growth Metrics

Lipocine (LPCN) Cash from Investing Activities (2016 - 2025)

Lipocine's Cash from Investing Activities history spans 13 years, with the latest figure at $701449.0 for Q3 2025.

  • For Q3 2025, Cash from Investing Activities fell 31.4% year-over-year to $701449.0; the TTM value through Sep 2025 reached $5.1 million, up 15.16%, while the annual FY2024 figure was $2.4 million, 81.31% down from the prior year.
  • Cash from Investing Activities reached $701449.0 in Q3 2025 per LPCN's latest filing, down from $4.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7.3 million in Q1 2022 to a low of -$34.0 million in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$507187.7, with a median of $1.2 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: plummeted 971.15% in 2021, then skyrocketed 364.53% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at -$9.7 million in 2021, then skyrocketed by 126.7% to $2.6 million in 2022, then increased by 5.02% to $2.7 million in 2023, then plummeted by 72.09% to $761058.0 in 2024, then decreased by 7.83% to $701449.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Cash from Investing Activities are $701449.0 (Q3 2025), $4.5 million (Q2 2025), and -$882073.0 (Q1 2025).